| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | bisphosphoglycerate mutase activity | 1.31e-07 | 4 | 65 | 3 | GO:0004082 | |
| GeneOntologyMolecularFunction | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity | 1.31e-07 | 4 | 65 | 3 | GO:0046538 | |
| GeneOntologyMolecularFunction | phosphoglycerate mutase activity | 1.31e-07 | 4 | 65 | 3 | GO:0004619 | |
| GeneOntologyMolecularFunction | intramolecular phosphotransferase activity | 5.33e-06 | 11 | 65 | 3 | GO:0016868 | |
| GeneOntologyMolecularFunction | L-lactate dehydrogenase activity | 1.04e-04 | 5 | 65 | 2 | GO:0004459 | |
| GeneOntologyMolecularFunction | intramolecular transferase activity | 1.13e-04 | 29 | 65 | 3 | GO:0016866 | |
| GeneOntologyMolecularFunction | lactate dehydrogenase activity | 1.55e-04 | 6 | 65 | 2 | GO:0004457 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.54e-03 | 18 | 65 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.88e-03 | 749 | 65 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | isomerase activity | 3.55e-03 | 192 | 65 | 4 | GO:0016853 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.73e-03 | 28 | 65 | 2 | GO:0051959 | |
| GeneOntologyBiologicalProcess | adaptive thermogenesis | 1.93e-05 | 176 | 65 | 6 | GO:1990845 | |
| GeneOntologyBiologicalProcess | hexose catabolic process | 2.34e-05 | 53 | 65 | 4 | GO:0019320 | |
| GeneOntologyBiologicalProcess | monosaccharide catabolic process | 3.13e-05 | 57 | 65 | 4 | GO:0046365 | |
| GeneOntologyBiologicalProcess | carbohydrate catabolic process | 3.53e-05 | 196 | 65 | 6 | GO:0016052 | |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 5.34e-05 | 310 | 65 | 7 | GO:0005996 | |
| GeneOntologyBiologicalProcess | GDP-L-fucose metabolic process | 5.84e-05 | 4 | 65 | 2 | GO:0046368 | |
| GeneOntologyBiologicalProcess | pyruvate metabolic process | 8.54e-05 | 142 | 65 | 5 | GO:0006090 | |
| GeneOntologyBiologicalProcess | cold-induced thermogenesis | 1.33e-04 | 156 | 65 | 5 | GO:0106106 | |
| GeneOntologyBiologicalProcess | glucose catabolic process | 1.39e-04 | 32 | 65 | 3 | GO:0006007 | |
| GeneOntologyBiologicalProcess | nuclear migration | 1.67e-04 | 34 | 65 | 3 | GO:0007097 | |
| GeneOntologyBiologicalProcess | hexose metabolic process | 2.70e-04 | 284 | 65 | 6 | GO:0019318 | |
| GeneOntologyBiologicalProcess | negative regulation of viral process | 3.14e-04 | 103 | 65 | 4 | GO:0048525 | |
| GeneOntologyBiologicalProcess | nucleus localization | 3.61e-04 | 44 | 65 | 3 | GO:0051647 | |
| GeneOntologyBiologicalProcess | temperature homeostasis | 3.83e-04 | 196 | 65 | 5 | GO:0001659 | |
| GeneOntologyBiologicalProcess | glycolytic process | 4.04e-04 | 110 | 65 | 4 | GO:0006096 | |
| GeneOntologyBiologicalProcess | ADP catabolic process | 4.62e-04 | 114 | 65 | 4 | GO:0046032 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate catabolic process | 5.10e-04 | 117 | 65 | 4 | GO:0009137 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate catabolic process | 5.10e-04 | 117 | 65 | 4 | GO:0009181 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide catabolic process | 5.44e-04 | 119 | 65 | 4 | GO:0019364 | |
| GeneOntologyBiologicalProcess | ADP metabolic process | 5.61e-04 | 120 | 65 | 4 | GO:0046031 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate catabolic process | 5.79e-04 | 121 | 65 | 4 | GO:0009191 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound catabolic process | 6.16e-04 | 123 | 65 | 4 | GO:0072526 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate catabolic process | 6.35e-04 | 124 | 65 | 4 | GO:0009134 | |
| GeneOntologyCellularComponent | sperm principal piece | 1.26e-05 | 44 | 68 | 4 | GO:0097228 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.24e-04 | 238 | 68 | 6 | GO:0097729 | |
| Domain | Phosphogly_mut1 | 1.68e-07 | 4 | 66 | 3 | IPR005952 | |
| Domain | PG/BPGM_mutase_AS | 3.49e-06 | 9 | 66 | 3 | IPR001345 | |
| Domain | PGAM | 4.97e-06 | 10 | 66 | 3 | SM00855 | |
| Domain | PG_MUTASE | 4.97e-06 | 10 | 66 | 3 | PS00175 | |
| Domain | His_Phos_1 | 9.06e-06 | 12 | 66 | 3 | PF00300 | |
| Domain | His_Pase_superF_clade-1 | 9.06e-06 | 12 | 66 | 3 | IPR013078 | |
| Domain | ATPase_dyneun-rel_AAA | 1.49e-05 | 14 | 66 | 3 | IPR011704 | |
| Domain | AAA_5 | 1.49e-05 | 14 | 66 | 3 | PF07728 | |
| Domain | His_PPase_superfam | 4.60e-05 | 20 | 66 | 3 | IPR029033 | |
| Domain | - | 4.60e-05 | 20 | 66 | 3 | 3.40.50.1240 | |
| Domain | L-lactate_DH | 1.22e-04 | 5 | 66 | 2 | IPR011304 | |
| Domain | L-lactate_DH_AS | 1.22e-04 | 5 | 66 | 2 | IPR018177 | |
| Domain | L_LDH | 1.22e-04 | 5 | 66 | 2 | PS00064 | |
| Domain | - | 3.27e-04 | 169 | 66 | 5 | 3.40.50.720 | |
| Domain | L-lactate/malate_DH | 3.40e-04 | 8 | 66 | 2 | IPR001557 | |
| Domain | DHC_N1 | 3.40e-04 | 8 | 66 | 2 | PF08385 | |
| Domain | Ldh_1_N | 3.40e-04 | 8 | 66 | 2 | PF00056 | |
| Domain | Dynein_heavy_dom-1 | 3.40e-04 | 8 | 66 | 2 | IPR013594 | |
| Domain | Lactate/malate_DH_N | 3.40e-04 | 8 | 66 | 2 | IPR001236 | |
| Domain | NAD(P)-bd_dom | 3.64e-04 | 173 | 66 | 5 | IPR016040 | |
| Domain | - | 4.36e-04 | 9 | 66 | 2 | 3.90.110.10 | |
| Domain | Lactate/malate_DH_C | 4.36e-04 | 9 | 66 | 2 | IPR022383 | |
| Domain | Lactate_DH/Glyco_Ohase_4_C | 4.36e-04 | 9 | 66 | 2 | IPR015955 | |
| Domain | Ldh_1_C | 4.36e-04 | 9 | 66 | 2 | PF02866 | |
| Domain | Sialidases | 4.36e-04 | 9 | 66 | 2 | IPR011040 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.09e-03 | 14 | 66 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.09e-03 | 14 | 66 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.09e-03 | 14 | 66 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.09e-03 | 14 | 66 | 2 | PF08393 | |
| Domain | MT | 1.09e-03 | 14 | 66 | 2 | PF12777 | |
| Domain | AAA_8 | 1.09e-03 | 14 | 66 | 2 | PF12780 | |
| Domain | DHC_fam | 1.25e-03 | 15 | 66 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.25e-03 | 15 | 66 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.25e-03 | 15 | 66 | 2 | PF03028 | |
| Domain | LY | 1.25e-03 | 15 | 66 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.25e-03 | 15 | 66 | 2 | IPR000033 | |
| Domain | WD40 | 2.21e-03 | 259 | 66 | 5 | PF00400 | |
| Domain | WD40 | 2.57e-03 | 268 | 66 | 5 | SM00320 | |
| Domain | WD40_repeat | 2.74e-03 | 272 | 66 | 5 | IPR001680 | |
| Domain | WD_REPEATS_1 | 3.00e-03 | 278 | 66 | 5 | PS00678 | |
| Domain | WD_REPEATS_2 | 3.05e-03 | 279 | 66 | 5 | PS50082 | |
| Domain | WD_REPEATS_REGION | 3.05e-03 | 279 | 66 | 5 | PS50294 | |
| Domain | tRNA-bd_arm | 3.23e-03 | 24 | 66 | 2 | IPR010978 | |
| Domain | WD40_repeat_dom | 3.98e-03 | 297 | 66 | 5 | IPR017986 | |
| Domain | Serpin_CS | 5.70e-03 | 32 | 66 | 2 | IPR023795 | |
| Domain | - | 6.43e-03 | 333 | 66 | 5 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 6.59e-03 | 335 | 66 | 5 | IPR015943 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOLYSIS | 4.12e-08 | 25 | 56 | 5 | M47623 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 1.68e-06 | 51 | 56 | 5 | MM15928 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 4.49e-06 | 62 | 56 | 5 | M11521 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 2.95e-05 | 45 | 56 | 4 | M39474 | |
| Pathway | REACTOME_GLUCONEOGENESIS | 1.45e-04 | 26 | 56 | 3 | MM15392 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 3.10e-04 | 82 | 56 | 4 | MM15394 | |
| Pathway | WP_METABOLIC_EPILEPTIC_DISORDERS | 4.62e-04 | 91 | 56 | 4 | M48079 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TGM2 MDN1 PRRC2C COPB2 PGAM4 PYGL HSD17B4 LDHA PGAM1 PGAM2 DYNC1H1 GSN FABP5 | 4.22e-10 | 647 | 69 | 13 | 26618866 |
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 33914812 | ||
| Pubmed | Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis. | 7.47e-09 | 3 | 69 | 3 | 32634742 | |
| Pubmed | Mouse phosphoglycerate mutase M and B isozymes: cDNA cloning, enzyme activity assay and mapping. | 7.47e-09 | 3 | 69 | 3 | 11250083 | |
| Pubmed | Developmental activation of phosphoglycerate mutase-2 in the testis of the mouse. | 7.47e-09 | 3 | 69 | 3 | 2824255 | |
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 25195573 | ||
| Pubmed | MDN1 PRRC2C COPB2 DOCK7 PYGL WDR12 PGAM1 DIS3 DYNC1H1 WDR43 SEC13 | 6.39e-08 | 653 | 69 | 11 | 22586326 | |
| Pubmed | 4.16e-07 | 8 | 69 | 3 | 24567357 | ||
| Pubmed | 2.28e-06 | 191 | 69 | 6 | 33762435 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 3.16e-06 | 607 | 69 | 9 | 39147351 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 21285358 | ||
| Pubmed | Isolation of a cDNA encoding the muscle-specific subunit of human phosphoglycerate mutase. | 3.88e-06 | 2 | 69 | 2 | 2822696 | |
| Pubmed | Phosphoglycerate mutase isozyme marker for tissue differentiation in man. | 3.88e-06 | 2 | 69 | 2 | 4827367 | |
| Pubmed | Differing impact of phosphoglycerate mutase 1-deficiency on brown and white adipose tissue. | 3.88e-06 | 2 | 69 | 2 | 35521515 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 22590500 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 25701843 | ||
| Pubmed | Gene network of a phosphoglycerate mutase in muscle wasting in mice. | 3.88e-06 | 2 | 69 | 2 | 25644094 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 30720109 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 30460638 | ||
| Pubmed | T cell-specific deletion of Pgam1 reveals a critical role for glycolysis in T cell responses. | 3.88e-06 | 2 | 69 | 2 | 32709928 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 8829551 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 6.40e-06 | 497 | 69 | 8 | 36774506 | |
| Pubmed | 6.75e-06 | 132 | 69 | 5 | 22496890 | ||
| Pubmed | SETDB1 RELN CLSTN3 TTC17 SPARCL1 RRBP1 HSD17B4 USP9Y FUT8 CNOT3 DYNC1H1 RYR3 | 7.73e-06 | 1285 | 69 | 12 | 35914814 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | TGM2 SERPINB8 CLN5 PGAM4 PYGL LDHA PGAM1 PGAM2 DYNC1H1 GSN FABP5 | 7.92e-06 | 1070 | 69 | 11 | 23533145 |
| Pubmed | Molecular cloning and nucleotide sequence of murine 2,3-bisphosphoglycerate mutase cDNA. | 1.16e-05 | 3 | 69 | 2 | 2847721 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 16571669 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 24958256 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 33168191 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 37028703 | ||
| Pubmed | Lactate dehydrogenase is an AU-rich element-binding protein that directly interacts with AUF1. | 1.16e-05 | 3 | 69 | 2 | 12107167 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 38426579 | ||
| Pubmed | Evidence for an alternative glycolytic pathway in rapidly proliferating cells. | 1.16e-05 | 3 | 69 | 2 | 20847263 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MDN1 PRRC2C COPB2 DOCK7 PYGL LDHA PGAM1 DYNC1H1 GSN FABP5 SEC13 | 1.54e-05 | 1149 | 69 | 11 | 35446349 |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | 1.74e-05 | 571 | 69 | 8 | 37167062 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MDN1 DNAH10 COPB2 DOCK7 WDR12 RRBP1 HSD17B4 LDHA PGAM1 DIS3 DYNC1H1 WDR43 | 2.16e-05 | 1425 | 69 | 12 | 30948266 |
| Pubmed | SETDB1 CDC42BPA DNAH10 PRRC2C ARID2 COPB2 CEP152 JMJD1C CNOT3 DYNC1H1 SEC13 SORL1 | 2.23e-05 | 1429 | 69 | 12 | 35140242 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 23512986 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TGM2 OSBP COPB2 LDHAL6B GMDS PYGL WDR12 LDHA CERT1 DIS3 DYNC1H1 SEC13 | 2.66e-05 | 1455 | 69 | 12 | 22863883 |
| Pubmed | 2.92e-05 | 30 | 69 | 3 | 19936222 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 26601951 | ||
| Pubmed | A SOX17-PDGFB signaling axis regulates aortic root development. | 4.28e-05 | 34 | 69 | 3 | 35831318 | |
| Pubmed | 4.37e-05 | 650 | 69 | 8 | 38777146 | ||
| Pubmed | 4.81e-05 | 327 | 69 | 6 | 34428256 | ||
| Pubmed | 5.22e-05 | 488 | 69 | 7 | 31324722 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.23e-05 | 202 | 69 | 5 | 33005030 | |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 5.62e-05 | 104 | 69 | 4 | 36055981 | |
| Pubmed | Connexin Expression Is Altered in the Eye Development of Yotari Mice: A Preliminary Study. | 5.79e-05 | 6 | 69 | 2 | 39334940 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 18384059 | ||
| Pubmed | 6.49e-05 | 39 | 69 | 3 | 33059001 | ||
| Pubmed | TGM2 CDC42BPA PRRC2C DOCK7 WDR12 ROS1 RRBP1 LDHA DYNC1H1 WDR43 SEC13 | 7.66e-05 | 1371 | 69 | 11 | 36244648 | |
| Pubmed | 7.94e-05 | 708 | 69 | 8 | 39231216 | ||
| Pubmed | 8.03e-05 | 114 | 69 | 4 | 28245920 | ||
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 15728249 | ||
| Pubmed | 8.17e-05 | 360 | 69 | 6 | 33111431 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 8.42e-05 | 714 | 69 | 8 | 28302793 | |
| Pubmed | 8.52e-05 | 224 | 69 | 5 | 32941674 | ||
| Pubmed | An N-terminal motif unique to primate tau enables differential protein-protein interactions. | 9.49e-05 | 119 | 69 | 4 | 29382714 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRRC2C COPB2 GMDS RRBP1 HSD17B4 LDHA PGAM2 DIS3 DYNC1H1 GSN SEC13 | 1.01e-04 | 1415 | 69 | 11 | 28515276 |
| Pubmed | PRRC2C COPB2 PGAM4 DOCK7 RRBP1 LDHA PGAM1 DYNC1H1 GSN ITPKA SEC13 | 1.12e-04 | 1431 | 69 | 11 | 37142655 | |
| Pubmed | 1.21e-04 | 48 | 69 | 3 | 27872092 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 1.29e-04 | 564 | 69 | 7 | 21565611 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.59e-04 | 256 | 69 | 5 | 33397691 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.66e-04 | 588 | 69 | 7 | 38580884 | |
| Pubmed | 1.71e-04 | 591 | 69 | 7 | 15231748 | ||
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 32456285 | ||
| Pubmed | Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in vivo in the rat. | 1.73e-04 | 10 | 69 | 2 | 18662986 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 1.80e-04 | 1257 | 69 | 10 | 36526897 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | 1.80e-04 | 1257 | 69 | 10 | 37317656 | |
| Pubmed | 1.80e-04 | 263 | 69 | 5 | 12665801 | ||
| Pubmed | 1.86e-04 | 419 | 69 | 6 | 15635413 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 1.94e-04 | 422 | 69 | 6 | 27342126 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.95e-04 | 807 | 69 | 8 | 30575818 | |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | 1.96e-04 | 1031 | 69 | 9 | 16710414 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.97e-04 | 268 | 69 | 5 | 33024031 | |
| Pubmed | 2.08e-04 | 146 | 69 | 4 | 29688375 | ||
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 15203215 | ||
| Pubmed | 2.14e-04 | 147 | 69 | 4 | 16959763 | ||
| Pubmed | Maternal bile acid transporter deficiency promotes neonatal demise. | 2.24e-04 | 59 | 69 | 3 | 26416771 | |
| Pubmed | Diverse transcriptional initiation revealed by fine, large-scale mapping of mRNA start sites. | 2.53e-04 | 12 | 69 | 2 | 11375929 | |
| Pubmed | Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. | 2.60e-04 | 62 | 69 | 3 | 17975119 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 2.63e-04 | 1318 | 69 | 10 | 30463901 | |
| Pubmed | 2.68e-04 | 156 | 69 | 4 | 29961565 | ||
| Pubmed | 2.73e-04 | 63 | 69 | 3 | 17220478 | ||
| Pubmed | Gene variants associated with ischemic stroke: the cardiovascular health study. | 2.73e-04 | 63 | 69 | 3 | 19023099 | |
| Pubmed | 2.77e-04 | 451 | 69 | 6 | 36168627 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 2.80e-04 | 1082 | 69 | 9 | 38697112 | |
| Pubmed | 2.98e-04 | 13 | 69 | 2 | 11863365 | ||
| Pubmed | Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. | 3.03e-04 | 161 | 69 | 4 | 32572027 | |
| Pubmed | 3.23e-04 | 1103 | 69 | 9 | 34189442 | ||
| Pubmed | An analysis of expression patterns of genes encoding proteins with catalytic activities. | 3.27e-04 | 67 | 69 | 3 | 17626619 | |
| Pubmed | 3.43e-04 | 878 | 69 | 8 | 37223481 | ||
| Pubmed | Pax6 modulates the dorsoventral patterning of the mammalian telencephalon. | 3.48e-04 | 14 | 69 | 2 | 11050125 | |
| Pubmed | TRF2-mediated telomere protection is dispensable in pluripotent stem cells. | 3.48e-04 | 14 | 69 | 2 | 33239785 | |
| Pubmed | 3.48e-04 | 14 | 69 | 2 | 9373155 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 3.51e-04 | 1367 | 69 | 10 | 32687490 | |
| Pubmed | 3.98e-04 | 483 | 69 | 6 | 36912080 | ||
| Pubmed | Composition of Drosophila melanogaster proteome involved in fucosylated glycan metabolism. | 4.01e-04 | 15 | 69 | 2 | 11698403 | |
| Pubmed | 4.08e-04 | 1139 | 69 | 9 | 36417873 | ||
| Pubmed | 4.54e-04 | 916 | 69 | 8 | 32203420 | ||
| Interaction | CASD1 interactions | 6.21e-06 | 11 | 69 | 3 | int:CASD1 | |
| Cytoband | 1p35.1 | 1.07e-03 | 32 | 69 | 2 | 1p35.1 | |
| GeneFamily | Bisphosphoglycerate phosphatases | 7.95e-08 | 4 | 50 | 3 | 1082 | |
| GeneFamily | WD repeat domain containing | 7.65e-04 | 262 | 50 | 5 | 362 | |
| GeneFamily | Neuroblastoma breakpoint family | 1.83e-03 | 23 | 50 | 2 | 662 | |
| Coexpression | TRAVAGLINI_LUNG_GOBLET_CELL | 2.40e-06 | 148 | 68 | 6 | M41655 | |
| Coexpression | GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP | 1.31e-05 | 199 | 68 | 6 | M5446 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN | 1.35e-05 | 200 | 68 | 6 | M8040 | |
| Coexpression | HALLMARK_GLYCOLYSIS | 1.35e-05 | 200 | 68 | 6 | M5937 | |
| Coexpression | GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN | 2.80e-05 | 136 | 68 | 5 | M41157 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 5.56e-05 | 157 | 68 | 5 | M7733 | |
| Coexpression | TRAVAGLINI_LUNG_DIFFERENTIATING_BASAL_CELL | 5.56e-05 | 157 | 68 | 5 | M41653 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 1.18e-04 | 295 | 68 | 6 | M39121 | |
| Coexpression | HAY_BONE_MARROW_CD34_POS_LYMPHOID_UNK | 1.38e-04 | 7 | 68 | 2 | M39184 | |
| Coexpression | YAGI_AML_FAB_MARKERS | 1.51e-04 | 194 | 68 | 5 | M5103 | |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_UP | 1.66e-04 | 198 | 68 | 5 | M8866 | |
| Coexpression | GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN | 1.74e-04 | 200 | 68 | 5 | M3264 | |
| Coexpression | GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP | 1.74e-04 | 200 | 68 | 5 | M3275 | |
| Coexpression | GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN | 1.74e-04 | 200 | 68 | 5 | M3525 | |
| Coexpression | GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN | 1.74e-04 | 200 | 68 | 5 | M5582 | |
| Coexpression | GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP | 1.74e-04 | 200 | 68 | 5 | M6212 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN | 1.74e-04 | 200 | 68 | 5 | M4412 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l8|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.02e-06 | 153 | 69 | 5 | 338684d420b01e32918fa19048ccdda234942ce1 | |
| ToppCell | CV-Mild-4|Mild / Virus stimulation, Condition and Cluster | 5.00e-06 | 160 | 69 | 5 | 2e24f8de5086b086863d3bf4d9afbd9bc93f4d5e | |
| ToppCell | lung-Club_Cells|lung / shred on tissue and cell subclass | 5.63e-06 | 164 | 69 | 5 | b12cacd499b18b96120ca6d14646aebeaed41d10 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 6.34e-06 | 168 | 69 | 5 | 76b49463895cdef27c90f831c6246bcb92b9761b | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-06 | 176 | 69 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Mild/Remission-B_memory-6|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.16e-06 | 177 | 69 | 5 | 8f2ce5ffc94ca90412cb6899629f322dc778215c | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-06 | 183 | 69 | 5 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-06 | 184 | 69 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-06 | 184 | 69 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | CV-Moderate-4|CV / Virus stimulation, Condition and Cluster | 9.85e-06 | 184 | 69 | 5 | 90f5b447064743246b09a6c47bf561efafa15e1f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-06 | 184 | 69 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | CV-Moderate-4|Moderate / Virus stimulation, Condition and Cluster | 1.01e-05 | 185 | 69 | 5 | 4a3ce0c603c2ffe11f0f00775b6af4f6d9a6070a | |
| ToppCell | CD8+_Memory_T_cell-CV-4|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.06e-05 | 187 | 69 | 5 | 9c2fc2f259fa7d3a65fb99c295ac378e03d9aa6c | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.12e-05 | 189 | 69 | 5 | 56156325cc36b1329bf483f81bb74f371ef15e20 | |
| ToppCell | COVID-19-Heart-Mito_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.15e-05 | 190 | 69 | 5 | ea74e0e38bcaba125b48c88331e9ba09228d3178 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.18e-05 | 191 | 69 | 5 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.21e-05 | 192 | 69 | 5 | 5841378789d8267f94071df060debc9171700784 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NK|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.24e-05 | 193 | 69 | 5 | 1b29525c5936d1b779253b8c20f059fa091c6127 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-05 | 193 | 69 | 5 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.30e-05 | 195 | 69 | 5 | 9b4f217325afb2efb9c65f298ac87649cb1e1af9 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 195 | 69 | 5 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | ASK452|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.30e-05 | 195 | 69 | 5 | 7efd9d3a3f5e7dfe9698a4143ce4a0f9bf3a862c | |
| ToppCell | Severe-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.47e-05 | 200 | 69 | 5 | 6d0cd00e52568d23597cc2a4059bd967d7d2dab5 | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 5.12e-05 | 131 | 69 | 4 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.60e-05 | 145 | 69 | 4 | ac41c6c02b7d78162b86222983688f54d04ac47d | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 157 | 69 | 4 | 9021900d9b1a71210c9c414a9d165eaf399eb607 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 157 | 69 | 4 | c8c627ca181856cd31dba4cf073c2be659a49dc1 | |
| ToppCell | 10x5'-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 1.09e-04 | 159 | 69 | 4 | c3d3570e83c5d25cc92fa3a7a8f0dc2f89a72913 | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 1.14e-04 | 161 | 69 | 4 | 15ba7e69699558353cfeecdcf1dbc2e147379ed6 | |
| ToppCell | Bronchial_Biopsy-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.17e-04 | 162 | 69 | 4 | 985adca17b0c99563feef7910f3da5df31e636b6 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-04 | 163 | 69 | 4 | d2fcd6f561748f7d29a051c504f016952ba32d0f | |
| ToppCell | Influenza_Severe-cDC|World / Disease group and Cell class | 1.22e-04 | 164 | 69 | 4 | c984228f73b9aa1aaf948541f64f41ed874770cd | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 164 | 69 | 4 | 8e6dbddacd56a07769163813e3ebfad13302bb62 | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 165 | 69 | 4 | fbd84f211ad645c91b9f45a0815391606f3206ac | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 165 | 69 | 4 | 6fbdfacb49e627712ac999d40ae22dcb390edd3e | |
| ToppCell | Mild/Remission-B_memory-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.28e-04 | 166 | 69 | 4 | 03e1a369d8a83b814def07e29cabb023226b4828 | |
| ToppCell | E17.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.37e-04 | 169 | 69 | 4 | 56aa58636ec624819ca88c8c27a7493c3f8c49fc | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-04 | 170 | 69 | 4 | 4848965bc7e9356c6601bb41eeea1553d2eea87e | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Prlr_(Entorhinal_cortex?)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.41e-04 | 65 | 69 | 3 | 57d0d892dab8bc8465067feeff279c967a43b781 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Prlr_(Entorhinal_cortex?)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.41e-04 | 65 | 69 | 3 | aba26f607f35c2920cdf956309285ad9e7b758a7 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 171 | 69 | 4 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 171 | 69 | 4 | 1701dedf0c18751db6c9fee3d93fff150ed0e17f | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 171 | 69 | 4 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.57e-04 | 175 | 69 | 4 | f6a6db992e803d36c866a91706b02f67e0fd3e09 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 175 | 69 | 4 | 0801cccec6915aefc135262fc74580280fd51aa5 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-04 | 175 | 69 | 4 | ba1befc4e5f0167452f9ceace39377d16136dfa9 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 175 | 69 | 4 | 09163e7030f76d706eccabdb1d5ec45f8412aa75 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 177 | 69 | 4 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | Severe-B_memory-6|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.64e-04 | 177 | 69 | 4 | c4c3511782d5febd0c8b369eebe9355ad3c3bcf2 | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 177 | 69 | 4 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.79e-04 | 181 | 69 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-04 | 182 | 69 | 4 | 243c783675df495ea4112dbf710712c44ea6b4f1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 182 | 69 | 4 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-04 | 182 | 69 | 4 | 18790a394dc32b3cef99cdbf826392c520e38b4a | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-04 | 183 | 69 | 4 | 28e1fc6498aaf8f42c4d6d4fa54ffff4c546d0d1 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 183 | 69 | 4 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-04 | 183 | 69 | 4 | 667d9107af17fd076ceff6b2cbcb78f892fd62d2 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.90e-04 | 184 | 69 | 4 | 0efc757d9512d6a8fe8176e977a94e4494ed9778 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 184 | 69 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.94e-04 | 185 | 69 | 4 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 185 | 69 | 4 | e583f6601f9ed79b0b23d2f9426a4ba8b969230b | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 185 | 69 | 4 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 185 | 69 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 186 | 69 | 4 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 1.98e-04 | 186 | 69 | 4 | 9ff3c30b1728707bb8f9422941333fe3b2c430f4 | |
| ToppCell | facs-SCAT-Fat-24m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 187 | 69 | 4 | 43e35ec995afd8780893de42ac4ee466794991d7 | |
| ToppCell | facs-SCAT-Fat-24m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 187 | 69 | 4 | 8ca9481d661626f6f0e1b61eb142b051192a9208 | |
| ToppCell | facs-SCAT-Fat-24m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 187 | 69 | 4 | 51336037dfd4bbe9fe9ce1e5b6b92d037156690c | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 188 | 69 | 4 | e079a3873cf442e98ff41a240c80b80995aace11 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 189 | 69 | 4 | e4efbb0733b382f4c855f6653dcddf36e0f8df28 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 189 | 69 | 4 | 7ee9b00a8bd46f2da9218623bb2617b2e585f9d5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Dendritic|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.11e-04 | 189 | 69 | 4 | c2a936f1008d691dac900f033a8a0f425dcf310b | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.11e-04 | 189 | 69 | 4 | 94dd5d4d815449feff7ce157fe7f8234f7c81422 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Dendritic-conventional_dendritic_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.11e-04 | 189 | 69 | 4 | 2cb730488709bcb56ce3468f3d74366d8bce9c72 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-04 | 190 | 69 | 4 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 2.15e-04 | 190 | 69 | 4 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | E18.5|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-04 | 190 | 69 | 4 | fe9678be25e29a09c0b9ac59da4ee3a29f22dde1 | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 2.15e-04 | 190 | 69 | 4 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.19e-04 | 191 | 69 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.19e-04 | 191 | 69 | 4 | 2ffd40ebf1d63e61a97208ddcbeb6a86e409f9d8 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.24e-04 | 192 | 69 | 4 | 02b11233b4da2d85b96498b3c6e22e3a31b3d049 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-04 | 192 | 69 | 4 | b877d14be9d04ab0010e340909e3a23de92613db | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 192 | 69 | 4 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | d8ccfb780a75bdf9141f41fb29a076958601ebb4 | |
| ToppCell | 11.5-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 2.28e-04 | 193 | 69 | 4 | d4779d92a4dd4b8b656383e6f4fce76d3bd70931 | |
| ToppCell | facs-Aorta-Heart-18m-Endothelial-aortic_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | 7b7fecd332d3c99b8810bd7e14ab33aab46f2ffd | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Aorta-Heart-18m-Endothelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | 7170cbaef0ba1b65cab89c5d4ce525e6c04e4418 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 193 | 69 | 4 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Aorta-Heart-18m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | 348a89bbf5fe7f7c875300c9ec3cb245c37e1308 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.28e-04 | 193 | 69 | 4 | 47249aabdd912052aa635d276eed20d32b525393 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Megakaryocyte|World / Lineage, cell class and subclass | 2.28e-04 | 193 | 69 | 4 | 352cd442b6e62f09b6d22a139774067873644594 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 193 | 69 | 4 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | 18-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 2.28e-04 | 193 | 69 | 4 | 9f4ba9c29ab8071d57e4187085ec3a47ab61e968 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 2.28e-04 | 193 | 69 | 4 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.33e-04 | 194 | 69 | 4 | aee60da2e7aed161cdd4abbfad6864665aaa8f5c | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 2.33e-04 | 194 | 69 | 4 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| Drug | glycolic acid | 4.09e-08 | 66 | 67 | 6 | CID000000757 | |
| Drug | bp G | 5.21e-06 | 39 | 67 | 4 | CID000448110 | |
| Drug | fructose-1,6-diphosphate sodium salt | 5.51e-06 | 151 | 67 | 6 | CID000000718 | |
| Drug | aldonates | 6.87e-06 | 90 | 67 | 5 | CID000000752 | |
| Drug | 2-phosphoglycerate | 8.50e-06 | 94 | 67 | 5 | CID000000059 | |
| Drug | Guanosine Monophosphate | 8.53e-06 | 2 | 67 | 2 | ctd:D006157 | |
| Drug | glucose-6-P | 1.18e-05 | 366 | 67 | 8 | CID000000208 | |
| Drug | 3-phosphoglycerate | 2.17e-05 | 114 | 67 | 5 | CID000000724 | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.23e-05 | 193 | 67 | 6 | 2829_UP | |
| Drug | Glafenine hydrochloride [65513-72-6]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 2.36e-05 | 195 | 67 | 6 | 7018_DN | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; HL60; HT_HG-U133A | 2.43e-05 | 196 | 67 | 6 | 2207_UP | |
| Drug | pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A | 2.57e-05 | 198 | 67 | 6 | 7506_DN | |
| Drug | InsP5 | 4.30e-05 | 66 | 67 | 4 | CID000000482 | |
| Drug | S-adenosylmethionine | 8.23e-05 | 355 | 67 | 7 | CID000001079 | |
| Drug | spirobishexahydropyrimidine | 8.48e-05 | 5 | 67 | 2 | CID000100750 | |
| Drug | AC1O5TJF | 8.48e-05 | 5 | 67 | 2 | CID006440410 | |
| Drug | 1,4-diethoxybutane | 8.48e-05 | 5 | 67 | 2 | CID000232578 | |
| Drug | S-lac-NAD | 8.48e-05 | 5 | 67 | 2 | CID000194292 | |
| Drug | sorbarin | 8.48e-05 | 5 | 67 | 2 | CID009824100 | |
| Drug | acetylphosphonic acid | 8.48e-05 | 5 | 67 | 2 | CID000081311 | |
| Drug | NSC-60195 | 8.48e-05 | 5 | 67 | 2 | CID000020481 | |
| Drug | ethyl gossypol | 8.48e-05 | 5 | 67 | 2 | CID000374353 | |
| Drug | AC1O5ZB9 | 8.48e-05 | 5 | 67 | 2 | CID006443605 | |
| Drug | AC1L49DG | 8.48e-05 | 5 | 67 | 2 | CID000152931 | |
| Drug | oxyayanin A | 8.48e-05 | 5 | 67 | 2 | CID005281676 | |
| Drug | B-HAD | 8.48e-05 | 5 | 67 | 2 | CID000131338 | |
| Drug | SQ 31,486 | 8.48e-05 | 5 | 67 | 2 | CID000130015 | |
| Drug | N-trifluoroacetyl-glycine | 8.48e-05 | 5 | 67 | 2 | CID000136227 | |
| Drug | BMS-188107 | 8.48e-05 | 5 | 67 | 2 | CID000192297 | |
| Drug | allulose 6-phosphate | 1.16e-04 | 162 | 67 | 5 | CID000000603 | |
| Drug | PtdIns(3,4)P | 1.27e-04 | 87 | 67 | 4 | CID000643960 | |
| Drug | AC1L24G8 | 1.27e-04 | 6 | 67 | 2 | CID000066023 | |
| Drug | BL-443 | 1.27e-04 | 6 | 67 | 2 | CID000054436 | |
| Drug | oxymethacil | 1.27e-04 | 6 | 67 | 2 | CID000096369 | |
| Drug | dansyl-L-lysine | 1.27e-04 | 6 | 67 | 2 | CID000598797 | |
| Drug | I 65 | 1.27e-04 | 6 | 67 | 2 | CID000149068 | |
| Drug | D 701 | 1.27e-04 | 6 | 67 | 2 | CID003051460 | |
| Drug | 2,3-dihydroxy-1-naphthoic acid | 1.27e-04 | 6 | 67 | 2 | CID000028002 | |
| Drug | SQ 32,926 | 1.27e-04 | 6 | 67 | 2 | CID000131363 | |
| Drug | asiatic acid | 1.49e-04 | 35 | 67 | 3 | CID000119034 | |
| Drug | S-allyl-L-cysteine | 1.62e-04 | 36 | 67 | 3 | CID000098280 | |
| Drug | N-acetylserine | 1.62e-04 | 36 | 67 | 3 | CID000065249 | |
| Drug | N-acetyl-9-O-lactylneuraminic acid | 1.77e-04 | 7 | 67 | 2 | CID000191486 | |
| Drug | sodium glycolate | 1.77e-04 | 7 | 67 | 2 | CID000517347 | |
| Drug | AC1O7170 | 1.77e-04 | 7 | 67 | 2 | CID006540699 | |
| Drug | AC1NSM0G | 1.77e-04 | 7 | 67 | 2 | CID005365671 | |
| Drug | BS35 | 1.77e-04 | 7 | 67 | 2 | CID000029316 | |
| Drug | BS36 | 1.77e-04 | 7 | 67 | 2 | CID000029308 | |
| Drug | pentabromoacetone | 1.77e-04 | 7 | 67 | 2 | CID000065579 | |
| Drug | methyl-4-hydroxy-3-nitrobenzimidate | 1.77e-04 | 7 | 67 | 2 | CID005492576 | |
| Drug | gossylic iminolactone | 1.77e-04 | 7 | 67 | 2 | CID005479302 | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; HL60; HT_HG-U133A | 2.00e-04 | 182 | 67 | 5 | 2576_UP | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.27e-04 | 187 | 67 | 5 | 3278_DN | |
| Drug | U75412E | 2.36e-04 | 8 | 67 | 2 | CID003035460 | |
| Drug | AC1Q3O0A | 2.36e-04 | 8 | 67 | 2 | CID000060880 | |
| Drug | UR-12633 | 2.36e-04 | 8 | 67 | 2 | CID000128030 | |
| Drug | p-(phenoxypropoxy)aniline | 2.36e-04 | 8 | 67 | 2 | CID000423258 | |
| Drug | 2-methyl-2-pentenoate | 2.36e-04 | 8 | 67 | 2 | CID000018458 | |
| Drug | BS37 | 2.36e-04 | 8 | 67 | 2 | CID000027925 | |
| Drug | AC1L4GHU | 2.36e-04 | 8 | 67 | 2 | CID000156607 | |
| Drug | N-dodecyl morpholine | 2.36e-04 | 8 | 67 | 2 | CID000073764 | |
| Drug | S-(2-chloroethyl)-L-cysteine | 2.36e-04 | 8 | 67 | 2 | CID000034229 | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 2.62e-04 | 193 | 67 | 5 | 1647_UP | |
| Drug | Indoprofen [31842-01-0]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.68e-04 | 194 | 67 | 5 | 3345_UP | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.68e-04 | 194 | 67 | 5 | 2223_UP | |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 2317_UP | |
| Drug | 5248896; Up 200; 11uM; MCF7; HT_HG-U133A_EA | 2.75e-04 | 195 | 67 | 5 | 838_UP | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 6159_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 1628_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 1487_UP | |
| Drug | Acacetin [480-44-4]; Up 200; 14uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 3849_UP | |
| Drug | Carisoprodol [78-44-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 3251_DN | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 1511_DN | |
| Drug | Glimepiride [93479-97-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 2809_UP | |
| Drug | Erythromycin [114-07-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 1510_UP | |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 2796_DN | |
| Drug | Naringin hydrate [11032-30-7]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 5666_DN | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 6097_UP | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; HL60; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 3011_UP | |
| Drug | Methyldopa (L,-) [555-30-6]; Up 200; 19uM; MCF7; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 3234_UP | |
| Drug | Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; HL60; HT_HG-U133A | 2.95e-04 | 198 | 67 | 5 | 1268_UP | |
| Drug | Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.95e-04 | 198 | 67 | 5 | 5501_DN | |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; HL60; HT_HG-U133A | 2.95e-04 | 198 | 67 | 5 | 2929_UP | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.95e-04 | 198 | 67 | 5 | 2234_UP | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; MCF7; HT_HG-U133A | 2.95e-04 | 198 | 67 | 5 | 5996_UP | |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; MCF7; HT_HG-U133A | 3.02e-04 | 199 | 67 | 5 | 3266_DN | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; PC3; HT_HG-U133A | 3.02e-04 | 199 | 67 | 5 | 7311_DN | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; HL60; HT_HG-U133A | 3.02e-04 | 199 | 67 | 5 | 3129_UP | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.02e-04 | 199 | 67 | 5 | 2251_UP | |
| Drug | DGM-2 | 3.03e-04 | 9 | 67 | 2 | CID000016891 | |
| Drug | benzamyl | 3.03e-04 | 9 | 67 | 2 | CID000160884 | |
| Drug | Bcdfg | 3.03e-04 | 9 | 67 | 2 | CID003036106 | |
| Drug | N-acetyl-ala-ala-ala-methyl ester | 3.03e-04 | 9 | 67 | 2 | CID000100120 | |
| Drug | Nitrofural [59-87-0]; Up 200; 20.2uM; HL60; HT_HG-U133A | 3.09e-04 | 200 | 67 | 5 | 2459_UP | |
| Drug | FK3311 | 3.78e-04 | 10 | 67 | 2 | CID000164009 | |
| Drug | 2-keto-4-mercaptobutyric acid | 3.78e-04 | 10 | 67 | 2 | CID000151198 | |
| Drug | methacryloyl chloride | 3.78e-04 | 10 | 67 | 2 | CID000013528 | |
| Drug | hydroxyisonobilin | 3.78e-04 | 10 | 67 | 2 | CID006438562 | |
| Drug | bis-NAD | 3.78e-04 | 10 | 67 | 2 | CID003081557 | |
| Drug | 2,2'-cyclouridine | 3.78e-04 | 10 | 67 | 2 | CID000098961 | |
| Disease | cholesterol in large VLDL measurement | 1.23e-05 | 65 | 64 | 4 | EFO_0021902 | |
| Disease | Glycogen Storage Disease | 2.74e-05 | 27 | 64 | 3 | C0017919 | |
| Disease | gro-beta/gamma measurement | 2.77e-05 | 4 | 64 | 2 | EFO_0020422 | |
| Disease | level of Phosphatidylinositol (16:0_18:2) in blood serum | 1.29e-04 | 8 | 64 | 2 | OBA_2045153 | |
| Disease | triglycerides in large VLDL measurement | 2.49e-04 | 56 | 64 | 3 | EFO_0022178 | |
| Disease | very low density lipoprotein cholesterol measurement | 2.55e-04 | 260 | 64 | 5 | EFO_0008317 | |
| Disease | total lipids in VLDL measurement | 3.05e-04 | 60 | 64 | 3 | EFO_0022314 | |
| Disease | triglycerides in small VLDL measurement | 3.20e-04 | 61 | 64 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 3.20e-04 | 61 | 64 | 3 | EFO_0022274 | |
| Disease | phospholipids in large VLDL measurement | 3.36e-04 | 62 | 64 | 3 | EFO_0022169 | |
| Disease | total lipids in very large VLDL measurement | 3.36e-04 | 62 | 64 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 3.36e-04 | 62 | 64 | 3 | EFO_0022299 | |
| Disease | triglycerides to total lipids in IDL percentage | 3.52e-04 | 63 | 64 | 3 | EFO_0022329 | |
| Disease | mood disorder | 3.56e-04 | 13 | 64 | 2 | EFO_0004247 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 3.56e-04 | 13 | 64 | 2 | OBA_2045159 | |
| Disease | cholesterol in very large VLDL measurement | 3.86e-04 | 65 | 64 | 3 | EFO_0022230 | |
| Disease | total lipids in small VLDL | 4.22e-04 | 67 | 64 | 3 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 4.22e-04 | 67 | 64 | 3 | EFO_0022175 | |
| Disease | triglycerides to phosphoglycerides ratio | 4.41e-04 | 68 | 64 | 3 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 4.41e-04 | 68 | 64 | 3 | EFO_0022265 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 4.60e-04 | 69 | 64 | 3 | EFO_0022341 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 4.77e-04 | 15 | 64 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | asthma, age at onset | 4.80e-04 | 70 | 64 | 3 | EFO_0004847, MONDO_0004979 | |
| Disease | Glycogen storage disease | 6.17e-04 | 17 | 64 | 2 | cv:C0017919 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 6.93e-04 | 18 | 64 | 2 | OBA_2045155 | |
| Disease | intermediate density lipoprotein measurement | 9.06e-04 | 87 | 64 | 3 | EFO_0008595 | |
| Disease | disease of metabolism (implicated_via_orthology) | 9.47e-04 | 21 | 64 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Primary Microcephaly | 1.04e-03 | 22 | 64 | 2 | C3711387 | |
| Disease | QT interval | 1.05e-03 | 534 | 64 | 6 | EFO_0004682 | |
| Disease | age of onset of childhood onset asthma | 1.06e-03 | 92 | 64 | 3 | OBA_2001015 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 1.17e-03 | 95 | 64 | 3 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.35e-03 | 220 | 64 | 4 | EFO_0004529, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.44e-03 | 224 | 64 | 4 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.46e-03 | 225 | 64 | 4 | EFO_0008317, EFO_0010351 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.60e-03 | 106 | 64 | 3 | EFO_0008317, EFO_0008596 | |
| Disease | susceptibility to rheumatic fever measurement | 1.69e-03 | 28 | 64 | 2 | EFO_0008416 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.78e-03 | 110 | 64 | 3 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.78e-03 | 110 | 64 | 3 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.78e-03 | 110 | 64 | 3 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 2.07e-03 | 31 | 64 | 2 | EFO_0022249 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KEWIQKKTVVHQGDG | 461 | Q5W0A0 | |
| KAEQKKWEEQHEVSV | 881 | O94986 | |
| ISHQVEAKKDESWQG | 676 | Q9BQT9 | |
| NGKIIWAKHSEVQQA | 311 | P35606 | |
| AKVSEKNQWGEIVEE | 61 | Q68CP9 | |
| QFHQIKVEKWSEGTT | 61 | O75952 | |
| KKVSEGVEQFEDIWQ | 16 | O75175 | |
| EGEKIKVQVWDTAGQ | 81 | Q14088 | |
| QWKEVHKQVVESAYE | 226 | P00338 | |
| QQWIDAIEQHKTESG | 106 | Q9Y5P4 | |
| WGTQEIIVAEFHKKI | 141 | Q5VUJ9 | |
| QIDHEVTVEKKWGQK | 1926 | Q9NU22 | |
| HIGKTIVWEGKNENE | 291 | O60547 | |
| HEEVKVWVKEQKVQE | 166 | Q15652 | |
| KDPEQWKNVHKEVTA | 271 | Q9BYZ2 | |
| AETAAKHGEAQVKIW | 101 | Q8N0Y7 | |
| TEAWDVQVHDQKIKE | 46 | Q9H4K1 | |
| WIDQSGEIDIVNHKT | 591 | P22059 | |
| QHQEWDGKESTITRK | 96 | Q01469 | |
| KGEETEKQSWAIDHV | 3211 | P78509 | |
| EAGEDVGQKNHWQKI | 156 | P23677 | |
| VQGTIKWREDHIANK | 506 | Q01638 | |
| KWVDNHKGVFNVEVV | 711 | Q96N67 | |
| VVHKDWNSDQVSKGN | 106 | P08218 | |
| SDHQKVDREEEWKQG | 156 | Q8WXQ3 | |
| EVVKKVNAVFEWHIT | 641 | P51659 | |
| QWITENEKFAEVGVK | 736 | Q9BYX4 | |
| HQVVETEQNKEVEKW | 1341 | Q5TB80 | |
| ETEEGVNKAAWQKTV | 2851 | Q99698 | |
| KGWENHVEGQKLKQD | 671 | Q14204 | |
| QVFVWVGKDSQEEEK | 706 | P06396 | |
| LDQVQEHSTVVGKIW | 11 | P35212 | |
| WEVEDVFHKAQKGEK | 1691 | Q8IVF4 | |
| AETAAKHGEAQVKIW | 101 | P18669 | |
| TAATVAGVHVKQQWD | 16 | Q6UWS5 | |
| HWSGEVKDKNVQVVE | 276 | Q9BYC5 | |
| GEGQWEVKKINNAHT | 136 | P55735 | |
| VVHWAGEKSNVIVAL | 106 | Q92673 | |
| KDWVVELNHAVDSKG | 901 | A0AVI2 | |
| HRWDQVKKEDQEATG | 331 | Q8N660 | |
| HRWDQVKKEDQEATG | 331 | A0A087WUL8 | |
| AETAAKHGEEQVKIW | 101 | P15259 | |
| GTGWASKQEQHEEEK | 81 | Q9Y520 | |
| ENEKNKWVGVLSELH | 1186 | Q5VT25 | |
| ATVWIHGDNEENKEI | 261 | Q9Y2L1 | |
| HINDWVAEKTEGKIS | 131 | P50452 | |
| TWVIQKESEVAHVDQ | 66 | Q15047 | |
| RHGWEDVTKINKTEI | 321 | Q9UHE8 | |
| DDVHWKENGTLVQVA | 171 | O75503 | |
| VVDWIQQDDGSVHKS | 401 | P21980 | |
| ASEEEKGDVRHQKWI | 726 | A4UGR9 | |
| EKAGIIQDTWHKATQ | 676 | Q9P2E9 | |
| IHFVKGVWEKTVNTE | 16 | P40200 | |
| VHVWAQKGDQESKKA | 686 | Q9UQP3 | |
| VEVVAENYHNIWAKK | 2736 | Q15413 | |
| KHIQETEWQSQEGKT | 286 | Q14515 | |
| NINKWVENETHGKIK | 141 | O75635 | |
| NEVVVEFRWNKPKHE | 1061 | P08922 | |
| VKTIWQSKEIHEAGD | 6 | Q9UJT2 | |
| WAAQAGKHEAIVKNV | 436 | O00507 | |
| HWVVTEDGKIQQQVD | 41 | Q96AE7 | |
| KHIQKEIQRGVESWV | 61 | Q9H903 | |
| GEIWTKSVTQQIHFK | 191 | P10073 | |
| NLQALGVSKVEKEHW | 346 | Q53H54 | |
| IVGHTDVVKDVAWVK | 136 | Q9GZL7 | |
| KVEHTNTGTKWIDTQ | 206 | P06737 | |
| VVAEKTQWVIGLAHE | 356 | Q9BVG3 | |
| IQWVDDDKNVSKGVV | 1266 | O95405 | |
| DDKHIVEWNVQTCKV | 146 | Q15061 |